Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||ET8885 / 1||- / -|
Administered by: Other Purchased by: ??
Symptoms: Fatigue, Influenza, Migraine, Vomiting
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Other Medications: NAPROXEN
Preexisting Conditions: Medical History/Concurrent Conditions: Migraine
Diagnostic Lab Data:
CDC 'Split Type': GBPFIZER INC2021657332
Write-up: Migraine; Vomiting; Flu symptoms; Tiredness; This is a spontaneous report from a contactable consumer received from a regulatory authority. A 31-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: ET8885), via an unspecified route of administration on 02Jun2021 as 1st dose, single for COVID-19 immunization. Medical history included migraine from an unknown date and unknown if ongoing. Patient has not had symptoms associated with COVID-19 and not had a COVID-19 test. Patient is not enrolled in clinical trial. Concomitant medications included naproxen taken for migraine, start and stop date were not reported. The patient experienced flu symptoms, tiredness on 03Jun2021, migraine and vomiting on 04Jun2021. The reporter assessed all events as serious (medically significant). Patient has not tested positive for COVID-19 since having the vaccine. The outcome of the events was not recovered. No follow-up attempts are possible. No further information is expected.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166